Why has Cerus's INTERCEPT Blood System for platelets seen a 15% decrease in adoption rates among blood centers over the past quarter?

Introduction

The INTERCEPT Blood System for platelets by Cerus has experienced a 15% decrease in adoption rates among blood centers over the past quarter. This significant drop warrants a thorough investigation to identify the root cause and develop effective solutions. I'll approach this analysis systematically, examining both internal and external factors that could contribute to this decline.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be seasonal factors at play. Has this 15% decrease been compared to the same quarter last year?

Why it matters: Seasonal variations could explain the drop without indicating a larger problem. Expected answer: Yes, it's been compared to the same quarter last year. Impact on approach: If it's not seasonal, we'll need to look deeper into recent changes or market shifts.

• Considering the specificity of the decrease, I'm wondering about the measurement accuracy. Has there been any change in how adoption rates are calculated or tracked?

Why it matters: Ensures we're addressing a real issue, not a data anomaly. Expected answer: No changes in measurement methods. Impact on approach: If there have been changes, we'd need to reassess the data before proceeding.

• Given the nature of the product, I'm curious about regulatory impacts. Have there been any recent regulatory changes affecting blood centers or the INTERCEPT system?

Why it matters: Regulatory changes could significantly impact adoption rates. Expected answer: No major regulatory changes recently. Impact on approach: If there have been changes, we'd need to assess their impact on adoption decisions.

• Thinking about market dynamics, has there been any significant change in competitor offerings or pricing?

Why it matters: Competitive pressures could explain the adoption rate decrease. Expected answer: No major changes from competitors. Impact on approach: If there have been competitive shifts, we'd need to analyze our market positioning.